Back to results
US 2025/0144189 A1Published application
Asparagine racemase and uses thereof
AssigneeBioxel Inc.
InventorsPatrick R. GLEASON, Elazer R. EDELMAN
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a novel recombinant unidirectional asparagine racemase for the conversion of L-asparagine to D-asparagine. Such unidirectional asparagine racemase could be used in treating cancers (e.g., leukemias or lymphomas) that require exogenous L-asparagine. This innovative design offers a promising new approach to reduce detrimental side effects caused by current therapies.
Claims12
A recombinant asparagine racemase capable of converting L-asparagine to D-asparagine.
Dependencies are inferred from the claim text.